Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32.82 USD | +2.74% | +1.35% | +29.34% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.34% | 1.96B | |
+52.75% | 55.7B | |
+41.08% | 39.91B | |
-5.64% | 39.57B | |
-5.56% | 28.16B | |
+15.96% | 26.3B | |
-19.96% | 18.94B | |
+33.02% | 12.17B | |
+26.89% | 12.12B | |
+2.11% | 12.12B |
- Stock Market
- Equities
- KYMR Stock
- News Kymera Therapeutics, Inc.
- Oppenheimer Adjusts Kymera Therapeutics Price Target to $52 From $53